Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
We report a patient with fracture of a paclitaxol-eluting stent implanted for focal in-stent restenosis (ISR) with sirolimus-eluting stent fracture. This case report suggests that a drug-eluting stent (DES) implanted for ISR with DES fracture may develop recurrent stent fracture.
Watanabe
Toru
T
Tamura
Akira
A
Miyamoto
Kumie
K
Kadota
Junichi
J
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000628:therapy; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy; D017239:Paclitaxel / Q000008:administration & dosage; D011475:Prosthesis Failure; D012008:Recurrence; D019233:Retreatment; D020123:Sirolimus / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D017239:Paclitaxel; D020123:Sirolimus